Skyward Specialty Insurance Group, Inc. (SKWD) Key Metrics
SKWD valuation today
Trailing 12 months · as of October 17, 2026- Market cap
- $2.72B
- Enterprise value
- $2.65B
- P/E (TTM)
- 14.2 10-yr median 15.1
- Forward P/E
- 9.9
- PEG ratio
- 0.72
- Price / sales
- 1.6 10-yr median 1.5
- Price / book
- 1.9 10-yr median 2.1
- EV / EBITDA
- — 10-yr median 3.1
- Dividend yield
- —
- Beta
- 0.35
SKWD key metrics, 2012–2025
Fiscal year ended December 31, 2025 · U.S. dollarsSKWD valuation Price multiples at each fiscal year-end price.
SKWD returns How much profit the business earns on the capital it uses.
SKWD per-share figures Results divided by the shares outstanding at year-end.
SKWD financial health Debt, liquidity and how easily interest is covered.
SKWD efficiency & capital use Working capital cycle and where the cash goes.
SKWD valuation history
SKWD returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
SKWD debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
SKWD cash returned to shareholders
SKWD price vs earnings per share
SKWD key metrics
2012–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||
| Market capitalization | $2.14B | $2.09B | $1.30B | — | — | — | — | — |
| Enterprise value | $708.4M | $1.04B | $73.1M | — | — | — | — | — |
| P/E ratio | 12.6 | 17.6 | 15.1 | — | — | — | — | — |
| Price / sales | 1.5 | 1.8 | 1.4 | — | — | — | — | — |
| Price / book | 2.1 | 2.6 | 2.0 | — | — | — | — | — |
| Price / free cash flow | 5.3 | 7.0 | 3.9 | — | — | — | — | — |
| Price / operating cash flow | 5.2 | 6.9 | 3.8 | — | — | — | — | — |
| EV / sales | 0.5 | 0.9 | 0.1 | — | — | — | — | — |
| EV / EBITDA | 3.1 | 6.3 | 0.6 | — | — | — | — | — |
| EV / free cash flow | 1.8 | 3.4 | 0.2 | — | — | — | — | — |
| Earnings yield | 7.9% | 5.7% | 6.6% | — | — | — | — | — |
| Free cash flow yield | 18.8% | 14.4% | 25.8% | — | — | — | — | — |
| Share price at fiscal year-end | $51.11 | $50.54 | $33.88 | — | — | — | — | — |
| Per share | ||||||||
| Revenue per share | $33.76 | $27.74 | $23.37 | $16.93 | $16.50 | $12.82 | $5.80 | $2.62 |
| Earnings per share | $4.06 | $2.87 | $2.24 | $1.05 | $1.18 | −$2.14 | $0.29 | −$0.03 |
| Operating cash flow per share | $9.75 | $7.37 | $8.83 | $5.56 | $5.40 | $1.28 | $1.19 | — |
| Free cash flow per share | $9.62 | $7.27 | $8.74 | $5.50 | $5.33 | $1.22 | $1.13 | — |
| Cash per share | $37.06 | $28.40 | $35.33 | $20.59 | $20.47 | $2.14 | $2.05 | — |
| Book value per share | $24.11 | $19.19 | $17.25 | $11.21 | $13.12 | $2.17 | $5.27 | — |
| Tangible book value per share | $18.76 | $17.08 | $14.94 | $6.99 | $10.31 | −$0.23 | $3.36 | — |
| Capex per share | $0.13 | $0.10 | $0.08 | $0.06 | $0.07 | $0.06 | $0.06 | $0.00 |
| Debt per share | $2.87 | $2.89 | $3.36 | $4.46 | $3.96 | $0.92 | $2.65 | — |
| Shares outstanding | 41.9M | 41.4M | 38.3M | 37.6M | 32.5M | 34.9M | 37.6M | 37.6M |
| Change in shares outstanding | +1.2% | +8.0% | +1.9% | +15.8% | −7.1% | −7.1% | 0.0% | — |
| Returns & profitability | ||||||||
| Return on equity (ROE) | 18.9% | 16.3% | 15.9% | 9.3% | 15.3% | −54.5% | 5.5% | — |
| Return on invested capital (ROIC) | — | — | — | — | — | −58.8% | 6.2% | — |
| Return on assets (ROA) | 4.0% | 3.6% | 3.2% | 1.8% | 2.9% | −10.5% | 1.2% | — |
| Return on tangible assets | 3.7% | 3.3% | 3.0% | 1.8% | 1.9% | −18.5% | 1.3% | — |
| Free cash flow margin | 28.5% | 26.2% | 37.4% | 32.5% | 32.3% | 9.5% | 19.5% | — |
| Income quality (OCF / net income) | 2.40 | 2.57 | 3.93 | 5.30 | 4.57 | — | 4.11 | — |
| Financial health | ||||||||
| Total debt | $120.0M | $119.5M | $128.7M | $167.7M | $128.5M | $32.1M | $99.8M | — |
| Cash & short-term investments | $1.55B | $1.18B | $1.35B | $774.2M | $664.7M | $74.9M | $77.2M | — |
| Net debt | −$1.43B | −$1.06B | −$1.23B | −$606.5M | −$536.2M | −$42.7M | $22.6M | — |
| Debt / equity | 0.12 | 0.15 | 0.19 | 0.40 | 0.30 | 0.42 | 0.50 | — |
| Debt / assets | 0.03 | 0.03 | 0.04 | 0.07 | 0.06 | 0.07 | 0.11 | — |
| Net debt / EBITDA | −6.28 | −6.38 | −9.88 | −10.06 | −9.16 | — | 1.35 | — |
| Current ratio | 0.95 | 6.41 | 0.26 | 9.02 | 0.55 | 5.80 | 2.21 | — |
| Quick ratio | 0.95 | 8.36 | 0.51 | 11.49 | 0.80 | 17.15 | 2.21 | — |
| Interest coverage | 27.3 | 16.1 | 11.0 | 7.8 | 10.5 | -17.1 | — | — |
| Working capital | −$177.0M | $2.16B | −$1.63B | $1.33B | −$708.7M | $197.1M | $42.3M | — |
| Invested capital | −$422.1M | −$261.7M | −$564.0M | −$184.8M | −$110.1M | $33.1M | $220.9M | — |
| Tangible asset value | $785.4M | $706.7M | $572.6M | $262.9M | $334.7M | −$8.2M | $126.2M | — |
| Net current asset value | −$297.0M | −$376.8M | −$1.71B | −$452.7M | −$837.3M | −$173.2M | −$659.1M | — |
| Graham number | $46.94 | $35.21 | $29.51 | $16.26 | $18.67 | — | $5.86 | — |
| Graham net-net per share | −$23.47 | −$30.56 | −$16.49 | −$22.26 | −$22.88 | −$12.80 | −$16.53 | — |
| Capital allocation | ||||||||
| Share buybacks (net) | — | — | — | $0 | $0 | $540,000 | — | — |
| Dividends + buybacks / free cash flow | — | — | — | 0.0% | 0.0% | 1.3% | — | — |
| Capex / revenue | 0.4% | 0.4% | 0.4% | 0.4% | 0.4% | 0.5% | 0.9% | 0.0% |
| Capex / operating cash flow | 1.3% | 1.4% | 0.9% | 1.1% | 1.2% | 4.6% | 4.6% | — |
| Capex / depreciation | 1.54 | 1.26 | 0.81 | 0.57 | 0.38 | 0.35 | 0.35 | — |
| Stock-based compensation / revenue | 0.8% | 0.8% | 1.0% | 0.4% | 0.1% | −0.0% | — | — |
| Efficiency | ||||||||
| Days sales outstanding | 367.1 | 310.9 | 304.9 | 392.6 | 276.5 | 87.0 | 84.1 | — |
| Days of inventory on hand | — | -295.5 | -280.4 | -316.5 | -395.4 | -426.5 | — | — |
| Days payables outstanding | 148.8 | 101.1 | 107.3 | 127.2 | 91.7 | 37.6 | — | — |
| Cash conversion cycle (days) | 218.3 | -85.7 | -82.7 | -51.1 | -210.7 | -377.0 | — | — |
| Receivables turnover | 0.99 | 1.17 | 1.20 | 0.93 | 1.32 | 4.19 | 4.34 | — |
| Payables turnover | 2.45 | 3.61 | 3.40 | 2.87 | 3.98 | 9.71 | — | — |
| Asset turnover | 0.33 | 0.34 | 0.34 | 0.28 | 0.41 | 0.63 | 0.23 | — |
| Average receivables | $1.42B | $977.5M | $748.1M | $684.5M | $405.9M | $106.8M | $50.3M | — |
| Average payables | $324.1M | $227.2M | $183.4M | $163.2M | $100.9M | $41.1M | — | — |
| Average inventory | — | −$663.6M | −$479.2M | −$406.0M | −$435.0M | −$466.4M | — | — |
| Intangibles / total assets | 4.7% | 2.3% | 3.0% | 6.7% | 4.3% | 17.2% | 7.7% | — |
Computed from SKWD's annual financial statements (latest annual report filed March 2, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
SKWD valuation and financial ratios
At the end of fiscal 2025 (December 31, 2025), Skyward Specialty Insurance traded at 12.6 times earnings, against a 8-year median of 15.1. Based on the latest twelve months, the trailing P/E is 14.2 and the forward P/E is 9.9. Skyward Specialty Insurance earned a return on equity of 18.9% in fiscal 2025. It ended the year with $120.0 million of debt and $1.6 billion in cash and short-term investments, a net cash position of $1.4 billion. The share count rose 11.4% from 37.6M to 41.9M over 7 years.
See the SKWD income statement, the SKWD chart for price history, or the SKWD stock overview for the latest quote and news.
SKWD key metrics FAQ
What is Skyward Specialty Insurance's P/E ratio?
Skyward Specialty Insurance's trailing P/E ratio is 14.2 based on the last twelve months of earnings (as of October 17, 2026), and its forward P/E is 9.9. At the end of fiscal 2025 it was 12.6, compared with a 8-year median of 15.1.
What is Skyward Specialty Insurance's EV/EBITDA?
Skyward Specialty Insurance's enterprise value was 3.1 times EBITDA at the end of fiscal 2025 (enterprise value $708.4 million, EBITDA $227.9 million).
What is Skyward Specialty Insurance's return on equity?
Skyward Specialty Insurance's return on equity (ROE) was 18.9% in fiscal 2025: net income of $170.0 million on average shareholders' equity of $901.8 million.
How much debt does Skyward Specialty Insurance have?
Skyward Specialty Insurance had total debt of $120.0 million at the end of fiscal 2025, a debt-to-equity ratio of 0.12 and more cash than debt.
What is Skyward Specialty Insurance's free cash flow yield?
Skyward Specialty Insurance generated $402.6 million of free cash flow in fiscal 2025, a free cash flow yield of 18.8% on its market value at year-end ($2.1 billion).
What is Skyward Specialty Insurance's current ratio?
Skyward Specialty Insurance's current ratio was 0.95 at the end of fiscal 2025: current assets were 0.95 times current liabilities.